Примери за използване на Patients reported на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Scientific research shows that 95% of treated patients reported significant improvement in their quality of life.
Overall, in the studies of general populations, 81% of patients reported that Cialis‘on demand' improved their erections as compared to 35% of those taking placebo.
In the everolimus group, 6.0% of patients reported an arterial thromboembolism(4.0% were Grade≥ 3).
In clinical studies, 86% of patients reported Sonicare AirFloss Pro was easier to use than floss.
Other studies have shown that GABA increases the body's sleeping cycle and patients reported much more vivid dreams.
After 3 weeks of Soliris treatment, patients reported less fatigue
Overall, in the studies of general populations, 81% of patients reported that tadalafil‘ on demand' improved their erections as compared with 35% of those taking placebo.
Patients reported higher satisfaction when they received physical therapy through direct access instead of referral through physician[3, 30].
less than 0.1% of the patients reported anaemia.
After 3 weeks of Soliris treatment, patients reported less fatigue
Indeed, a few of the patients reported use of other substances in addition to e-cigarettes,
Four of these patients reported isolated events of urticaria, pruritus, rash,
Patients reported more satisfaction with their quality of life
Two patients reported increased liver biochemical tests(alanine aminotransferase(ALT)
Some patients reported that their symptoms developed over a few days,
Patients reported a higher level of satisfaction when they received physical therapy through Direct Access versus physician referral.
More patients reported serious adverse events in the zoledronic acid group than in the placebo group(5[27.8%]
All patients reported risk factors for PRCA such as parvovirus B19 infection,
87% of patients reported a change in their sense of taste.
Two patients reported severe hypoglycaemic events in the vildagliptin group,